The smallest histone deacetylase (HDAC) and the only class IV HDAC member, HDAC11, is reported to regulate immune activation and tumorigenesis, yet its physiological function is largely unknown. Here we identify HDAC11 as an efficient lysine defatty-acylase that is >10,000-fold more efficient than its deacetylase activity. Through proteomics studies, we identified SHMT2 as a defatty-acylation substrate of HDAC11.
(Figure S1A) on H3K9 peptides bearing different acyl groups ( Figure 1A ). Using an HPLCbased assay, we found HDAC11 could efficiently remove long chain fatty-acyl groups (myristoyl, palmitoyl, and 3-hydroxydodecanoyl) from H3K9 peptides ( Figure 1A and 1B) .
Surprisingly, HDAC11 failed to remove smaller acyl groups, including octanoyl and decanoyl, from H3K9 peptides ( Figure 1A and 1B) . Similarly, many other acyl groups tested, including lipoyl, succinyl, and glutaryl on H3K9 peptides were not HDAC11 substrates ( Figure 1A) . To further compare the deacetylation and demyristoylation activities of HDAC11, we also chose a few different peptide sequences. We detected demyristoylation activity of HDAC11 on H2BK12 and TNFα peptides, but did not detect any deacetylation activity on H2BK12 and α-tubulin peptides ( Figure S1B ). Since Nterminal glycine myristoylation is a well-known posttranslational modification 19 , we also tested whether HDAC11 could catalyze glycine demyristoylation. No glycine demyristoylation activity was detected on p21-activated kinase 2 (PAK2) and Gα peptides ( Figure S1C ).
To rule out that the defatty-acylation activity was from a contaminating protein in the HDAC preparation, we further constructed and purified four catalytic mutants of HDAC11 that lack the general acid catalytic residue (Y304H) or zinc-binding residues (D181A, H183A, and D261A). Wild-type HDAC11, but not the catalytic mutants, could remove myristoyl group from the H3K9 peptide ( Figure 1C and Figure S1D ). Furthermore, we also detected the demyristoylation activity of recombinant HDAC11 purified from Saccharomyces cerevisiae ( Figure S1E ). We next carried out kinetics studies using H3 K9 myristoyl peptide as the substrate.
As shown in Figure 1D , the K m value for the myristoyl H3K9 peptide was 17.3 μM and catalytic efficiency (k cat /K m value) is 1.54×10 4 M -1 s -1 . For deacetylation, we could not obtain the k cat /K m value because no product was detected. But based on the detection limit of the HPLC assay, we estimated the upper limit of the k cat /K m value to be about 1 M -1 s -1 . Thus, the lysine defatty-acylase activity of HDAC11 is >10,000-fold more efficient than its deacetylase activity in vitro.
Proteomic approach identifies potential defatty-acylation substrates of HDAC11. To address whether the efficient defatty-acylation activity of HDAC11 is physiological relevant, we first tested the effect of HDAC11 knockdown (KD) on global lysine fatty-acylation level in MCF-7 cells, which had endogenous HDAC11 expression.
Using a metabolic labeling method ( Figure S2A ) with the Alk14 probe (an alkyne-tagged fatty acid analogue) for protein myristoylation and palmitoylation 18, 20 , intracellular fattyacylated proteins were labeled. The labeled proteins were then conjugated to a fluorescent tag (BODIPY-azide). After precipitating the proteins, hydroxylamine was used to remove cysteine acylation, and then the lysine acylated proteins were resolved by SDS-PAGE and visualized by in-gel fluorescence. As shown in Figure 2A , HDAC11 KD cells had increased global lysine fatty-acylation levels compared to control cells.
We then set out to identify potential defatty-acylation substrates of HDAC11 using proteomics. As shown in Figure 2B , we combined Alk14 labeling and stable isotope labeling with amino acid in cell culture (SILAC) to identify proteins with increased Alk14 labeling in HDAC11 KD or knockout (KO) cells. The SILAC experiments were carried out using three pairs of cell lines: wild-type (WT) and HDAC11 knockout (KO) HAP1 cells (SILAC1), control and HDAC11 KD HCT116 cells (SILAC2), and control and HDAC11 KD MCF-7 cells (SILAC3). The HDAC11 KO or KD cells were cultured with heavy amino acids while the corresponding control cells were cultured with light amino acids. The cells were labeled with Alk14 and the alkyne-labeled proteins were conjugated to a biotin tag (biotin-azide) via click chemistry. After the modified proteins were pulled down with streptavidin and treated with hydroxylamine, they were analyzed by mass spectrometry.
A protein with H/L ratio higher than 1 in SILAC could be a potential substrate of HDAC11.
To remove false positives and simplify downstream validation studies, we further filtered our data using the following criteria: heavy/light (H/L) ratio ≥1.2 with at least two peptides and protein score ≥10. Based on these criteria, we identified 139, 212, and 98 proteins in SILAC1 (Table S1 ), SILAC2 (Table S2 ) and SILAC3 (Table S3 ), respectively. Among them, 31 proteins were identified from at least two SILACs ( Figure 2C and Figure 2D ). In particular, one protein, serine hydroxymethyltransferase 2 (SHMT2), was identified from all three SILACs with H/L ratios ≥1.2 ( Figure 2D ). We therefore focused further validation studies on SHMT2.
SHMT2 is a defatty-acylation substrate of HDAC11 in cells. We first tested whether SHMT2 was a lysine fatty-acylated protein using Alk14 and fluorescent labeling ( Figure S2B ). Although some background fluorescent signal without Alk14 treatment was detected, Alk14 treatment increased the fluorescent signal of Flag-tagged SHMT2 (Flag-SHMT2, Figure 3A ), suggesting that SHMT2 contained fatty-acylation. Moreover, we detected the fatty-acylation of endogenous SHMT2 in cells ( Figure 3B ) using Alk14 labeling, biotin-azide conjugation, and streptavidin pulldown, followed by immunoblotting against SHMT2. Therefore, our data suggested that SHMT2 is a fatty-acylated protein.
Co-immunoprecipitation studies showed that overexpressed Flag-SHMT2 interacted with overexpressed HDAC11 with an HA tag in HEK 293T cells ( Figure S2C ).
To determine whether SHMT2 is a direct substrate of HDAC11, we first examined whether recombinant HDAC11 could remove the lysine fatty-acylation on SHMT2 in vitro.
Flag-SHMT2 was overexpressed in 293T cells and labeled with Alk14.
Immunoprecipitated SHMT2 was incubated with wild-type (WT) HDAC11 or the Y304H catalytic mutant (YH) of HDAC11. Then a fluorescent tag (BODIPY-azide) was conjugated using click chemistry and the fatty acylation level on SHMT2 was detected using in-gel fluorescence. As shown in Figure 3C , wild-type, but not mutant, HDAC11 significantly decreased the fluorescent signal on SHMT2, suggesting that HDAC11 can directly remove the fatty acyl groups on SHMT2.
In HEK 293T cells, co-overexpression of SHMT2 and WT HDAC11 decreased the fatty-acylation level on SHMT2, compared to cells without HDAC11 overexpression or cells overexpressing the Y304H catalytic mutant ( Figure 3D ). Thus, the enzymatic activity of HDAC11 is required for controlling SHMT2 fatty acylation in cells. Additionally, in MCF-7 cells, HDAC11 KD significantly increased endogenous SHMT2 fatty-acylation level compared to control KD ( Figure 3E ). Similar results were also observed in A549 and HCT116 cell lines ( Figure S3A ). Collectively, our in vitro and cellular data support the hypothesis that HDAC11 regulates the fatty-acylation level of SHMT2.
We next examined which lysine residue of SHMT2 was the fatty-acylation site. We first constructed a series of truncated forms of SHMT2 (Δ21, Δ134 and Δ202) ( Figure 3F) to narrow down the modification region. As shown in Figure 3G , all three truncated forms still had lysine fatty-acylation, suggesting the modified lysine is localized between residues 203 and 504 of SHMT2, which contained 16 lysine residues. Then, we mutated each of the 16 lysine (K) to arginine (R). Among them, 14 mutants were successfully expressed in HEK 293T cells ( Figure S3B ) while the other two could not be expressed.
Our results showed that only the K245R mutant significantly decreased the fatty acylation level, suggesting K245 is the major acylation site ( Figure 3H and Figure S3B ).
Interestingly, this lysine residue is not conserved in another isoform of SHMT in mammals, SHMT1. SHMT1 did not contain fatty acylation ( Figure S3C and Figure S3D ), which further supported that K245 is the major lysine fatty acylation site in SHMT2.
HDAC11 defatty-acylation of SHMT2 regulates IFNαR1 internalization and
stability. We next investigated the biological function of SHMT2 lysine fatty acylation. SHMT2, a metabolic enzyme involved in one-carbon metabolism, catalyzes the reversible interconversion of serine and tetrahydrofolate to glycine and methylenetetrahydrofolate 21, 22 . Thus, we first tested whether fatty-acylation might affect the enzymatic activity of SHMT2. As shown in Figure 4A , the enzymatic activity of SHMT2 K245R mutant was not significantly different from that of wild type SHMT2. Similarly, the enzymatic activity of SHMT2 was not significantly changed when co-expressed with either wild type or catalytic mutant of HDAC11 in 293T cells ( Figure 4B ). These observations suggested fattyacylation did not affect SHMT2 enzymatic activity. In line with these data, we also did not detect any difference in the oligomeric states of K245R mutant and wild type SHMT2 ( Figure S4A ), which forms an active tetramer 23 .
SHMT2 is mainly localized in the mitochondria and the subcellular localization of wild type SHMT2 and the K245R mutant in wild type or HDAC11 KO HAP1 cells was not significantly different ( Figure S4B and S4C). However, we did detect a small amount of SHMT2 that was localized in the cytosol ( Figure S4C ), which was consistent with previous reports 21, 24 . Given that the natural cytosolic isoform of SHMT2 (also known as SHMT2, referred to as Δ21 mutant here) also had lysine fatty-acylation ( Figure 3E and S4D), we concluded that lysine fatty acylation mainly occurred to the cytosolic SHMT2. Cytosolic SHMT2 was known to direct the BRCC36 containing complex (BRISC, a complex with deubiquitination activity) to deubiquitinate type I interferon receptor chain 1 (IFNR1), and thus decrease the internalization and increase the stability of IFNR1 24 . We thus tested whether HDAC11 affects the internalization and stability of IFNR1. As shown in Figure   4C and 4D, cell surface IFNR1 dramatically decreased due to internalization upon IFN treatment in wild type cells, but not in HDAC11 KD cells. Consistent with this, HDAC11 knockout dramatically decreased the ubiquitination level of IFNR1 compared to wild type cells ( Figure 4E ). Therefore, our data suggested that HDAC11 defatty-acylation of SHMT2 promoted IFNR1 ubiquitination and internalization.
HDAC11 regulates type I interferon signaling. IFNR1 is important for type I interferon signaling, which controls the activation of many genes that are important for immune response 25 . The protein stability of IFNR1 would affect the activation of downstream genes in type I interferon treated cells 24, 26 . Thus, HDAC11 may regulate type I interferon signaling via defatty-acylation of SHMT2. To test this, we measured expression of two classic IFNα-driven genes, ISG15 and PKR 25 . As shown in Figure 5A and 5B, ISG15 and PKR mRNA levels were increased in HDAC11 knockout cells more than those in WT HAP1 cells. Similarly, ISG15 and PKR mRNA levels were higher in HDAC11 KD MCF-7 cells than in control KD MCF-7 cells. As expected, re-expressing mouse HDAC11 in HDAC11 KO HAP1 cells diminished the increase of ISG15 and PKR expression ( Figure S5A ). Furthermore, knockdown of either SHMT2 or KIAA0157, key components of BRSIC 24 , diminished the increase of ISG15 and PKR mRNA level in HDAC11 knockout HAP1 cells ( Figure 5C and S5B), further supporting the idea that HDAC11 antagonizes type I interferon signaling via defatty-acylation of SHMT2, decreasing the recruitment of BRISC, and increasing the ubiquitination of IFNR1.
Type I interferon is released by mammalian cells in response to viral infections and helps cells to heighten their anti-viral defense 25 . Therefore, we further investigated whether HDAC11 could affect the viral defense of cells. We treated WT and HDAC11 knockout HAP1 cells with IFNα before infecting cells with lentiviruses carrying the GFP gene in a pCCL vector. The protein expression level of GFP would be reduced if there was increased anti-viral defense due to increased IFNR1 signaling in HDAC11 knockdown cells. Consistent with our hypothesis, HDAC11 knockout cells had reduced GFP protein levels compared to wild type HAP1 cells ( Figure 5D ).
To validate this phenotype in vivo, we further examined the IFNR1 signaling using transgenic mice model infected with vesicular stomatitis virus (VSV). The ISG15 and PKR mRNA levels in the lung and liver was measured after infecting with VSV for 2 days. As shown in Figure 5E , VSV viral infection upregulated the ISG15 and PKR mRNA level as expected. In line with the role of HDAC11 in regulating IFNR1 signaling in cells, we observed a significant increase of ISG15 and PKR mRNA level in lung and liver tissues from VSV-infected HDAC11 knockout mice comparing to those from wild-type animals ( Figure 5E ), consistent with the model that HDAC11 could antagonize type I interferon signaling ( Figure 5F ).
Discussion
In this study, we have identified HDAC11 as an efficient lysine defatty-acylase with catalytic efficiency >10,000 fold better than its deacetylase activity. This is the first time a zinc-dependent HDAC is found to have an activity that is much more efficient than its corresponding deacetylase activity. HDAC8 was recently reported to have defattyacylase activity, but the catalytic efficiency is only 2-3 fold better than that of deacetylation 12 . The studies with HDAC11 suggest that the zinc-dependent HDACs are similar to the sirtuin family of HDACs, where several members preferentially recognize acyl lysine modifications other than acetyl lysine, while some can remove multiple modifications with similar efficiencies 11, 13 . Among the zinc-dependent HDACs, class IIa HDACs lack detectable deacetylase activity 1 . The finding that HDAC11 has a novel efficient activity uncovers the possibility that class IIa HDACs may also be able to remove currently unknown acyl lysine modifications.
Our study identified a novel posttranslational mechanism that regulates a multifunctional protein, SHMT2 ( Figure 5F ). SHMT2 is a mitochondrial enzyme involved in one carbon metabolism 21, 22 . It has been reported that a shorter isoform, SHMT2, which lacks the N-terminal mitochondrial localization sequence, is present in the cytosol and nucleus 21 . The metabolic function of SHMT2 is thought to be critical for cancer cells and knockdown of SHMT2 inhibits the proliferation of several human cancer cells 27 .
Recently, SHMT2 was also reported to recruit the BRISC complex to IFNR1 to promote the deubiquitination of IFNR1 24 . Thus, SHMT2 appears to have multiple functions. Our study presented here indicate that SHMT2 is regulated by lysine fatty acylation, which has only been known to occur on a few proteins in mammalian cells. [28] [29] [30] [31] Our data suggest that lysine fatty acylation does not alter the enzymatic activity of SHMT2, but instead promotes the recruitment of the BRISC complex to IFNR1 ( Figure 5F ).. HDAC11 can remove the lysine fatty acylation on SHMT2, and thus increase the ubiquitination of IFNR1 and downregulate interferon signaling ( Figure 5F ).
Our results revealed a new immune-regulatory function of HDAC11 by connecting it to the interferon signaling pathway. It has been reported that HDAC11 overexpression suppresses LPS stimulated IL-10 transcription while HDAC11 knockdown increases LPSstimulated IL-10 transcription 10 . This has been explained by a model where HDAC11 binds to IL-10 promoter and deacetylates histones to suppress IL-10 transcription 10 . In this model, HDAC11 functions epigenetically at the end of the signaling pathway. In contrast, the HDAC11-IFNR1 ( Figure 5F ) regulation that we discovered here occurs at the beginning of the signaling pathway. Our model is based on the more efficient defattyacylase activity of HDAC11, while the previous model is based on the deacetylase activity of HDAC11. The two models are not mutually exclusive, or contradictory, since it is possible that HDAC11's deacetylase activity could be increased upon chromatin binding which allows for deacetylation of histones, while it functions efficiently as defatty-acylase in the cytosol. A similar mechanistic function has been reported for SIRT6, a member of the NAD + -dependent HDAC 31, 32 .
We demonstrated here that the regulation of the interferon signaling pathway is physiologically relevant for the antiviral response in human cell lines and in mice. Mice lacking HDAC11 can increase interferon signaling, which may subsequently more effectively clear viral infections. This finding significantly expands the physiological function of HDAC11 and opens up opportunities to develop HDAC11-specific inhibitors as therapeutics to treat disease where increased type I interferon signaling is beneficial, such as viral infection, 33 multiple sclerosis, 34 or cancer 35 .
Materials and Methods
Reagents. Anti-Flag affinity gel (cat log # A2220) and anti-Flag antibody conjugated with horseradish peroxidase (A8592) were purchased from Sigma-Aldrich. Antibodies against HDAC11 (sc-390737), β-actin (sc-4777), SHMT2 (sc-390641), GFP (sc-8334), and HA (sc-516102) were purchased from Santa Cruz Biotechnology. IFNαR1 (LS- 
Cell lines and plasmids construction. The CRISPR-cas9-based HAP1 HDAC11
KO and wild type HAP1 cell lines were purchased from Horizon (Cambridge, UK). HAP1 cells were cultured in IMDM medium supplemented with 10% FBS in a humidified atmosphere of 5% CO2 at 37°C. The MCF-7, HCT116, A549 and HEK293T cells were purchased from ATCC and cultured in DMEM or RPMI-1640 medium supplemented with 10% FBS (Invitrogen) in a humidified atmosphere with 5% CO2 at 37°C.
To generate stable overexpression cells, lentivirus was generated by co-transfection of pCDH containing the desired gene, pCMV-dR8.2, and pMD2.G plasmids into HEK293T cells. The cell medium was collected 48 h after transfection and used to infect cells of interest. After 72h, infected cells were further treated with 1.5 mg/mL puromycin to select for stable overexpression cells. Empty pCDH vector was used as negative controls.
The full-length coding sequences for human HDAC11 and SHMT2 were amplified from MCF-7 cDNA library, and mouse HDAC11 was amplified from MEF cDNA library using Platinum Pfx DNA polymerase (ThermoFisher). The genes were subsequently subcloned into the pCMV-tag 4A, pcDNA3.0-3'HA and/or pCDH plasmid (CD510B-1) with the The supernatant was gently removed by pipetting, and to each pellet was added 1 mL of methanol. The samples were again vortexed and spun down at 15,000 × g for 10 min at 4 °C. Then methanol was removed and the methanol wash step was repeated. After the second methanol wash, the protein pellets were air-dried for 10-15 min and then resolubilized in 20 μL of 4% SDS buffer (50 mM triethanolamine at pH 7.4, 150 mM NaCl, 4% (w/v) SDS) and followed by the click chemistry reaction using BODIPY-N3 as 
Detection of lysine fatty acylation on endogenous SHMT2 by western blot.
Cells were treated with or without 50 μM Alk14 for 6 h. The cells were collected by centrifugation at 1000 g for 5 min and then lysed in 4% SDS lysis buffer (50 mM triethanolamine at pH 7.4, 150 mM NaCl, 4% (w/v) SDS) with protease inhibitor cocktail into the reaction mixture. The click chemistry reaction was allowed to proceed at room temperature for 90 min. After incubation, 5 mL of methanol, 1.875 mL of chloroform, and 3.75 mL of water were added to each sample. After vortexing, the samples were centrifuged at 15,000 g for 20 min at 4 °C. The supernatant was gently removed by pipetting, and to each pellet was added 10 mL of methanol. The samples were again vortexed and spun down at 15,000 g for 10 min at 4 °C. The methanol was removed, and the protein pellets were washed again with 1 mL of methanol. After the second methanol wash, the protein pellets were air-dried for 15 min and then resolubilized in 0.5 mL of 4% SDS buffer. 1 mL of 1% Brij97 buffer (50 mM triethanolamine at pH 7.4, 150 mM NaCl, 1% (w/v) Brij97) was added to dilute the SDS concentration and then mixed with 100 μL of streptavidin agarose beads (ThermoFisher). The mixture was agitated for 1 h at room temperature. After washing the beads three times with washing buffer (PBS with 0.2% SDS), the beads were further treated with 0. The vessels were heated for 5 min in a boiling water bath to accelerate the formation of the HCHO dimedon derivative. The tubes were then cooled for 5 min in an ice bath before the dimedone compound was extracted by vigorous shaking with 1 mL of toluene. Two minutes of centrifugation separated the phases and 0.8 mL of upper phase were removed for scintillation counting analysis. Immunofluorescence and subcellular fractionation. Cells were fixed with 1 ml 4% paraformaldehyde (PFA) at room temperature for 0.5h, followed by washing samples three times in PBS buffer for 5 min each. Block samples in blocking buffer (5% BSA, 0.1% Saponin in PBS) for 0.5h at room temperature. After blocking, diluted primary antibody was applied (primary antibody was diluted in PBS containing 5% BSA and 0.1% Saponin) and the samples were incubated overnight at 4 °C. After washing the samples in PBS with 0.1% Saponin three times for 5 min each, the samples were incubated with fluorochrome-conjugated secondary antibody diluted in 1 mL of PBS with 5% BSA and 0.1% Saponin for another 1 h at room temperature in the dark. The samples were washed five times in PBS with 0.1% Saponin for 5 min each, and then one drop of antifade reagent (with DAPI) was applied. Confocal imaging was performed using a Zeiss LSM710 confocal microscope.
Subcellular fractionation was performed following our previous report with minimal modifications 31 . Briefly, cells were suspended in 500 μL of fractionation buffer (250 mM Sucrose, 20 mM pH 7.4 HEPEs, 10 mM KCl, 2 mM MgCl2, 1 mM, EDTA, 1 mM EGTA, and protease inhibitor cocktail) and passed through a 25G needle 20 times using a 1 mL syringe. The samples were placed on ice for 20 min, and then centrifuged at 800 g for 10 min. The Supernatant was transferred into a fresh tube and centrifuged again at 10,000 g for 10 min. The resulting pellet contained the mitochondria and the supernatant was the cytosolic fraction. The pellet was washed with 500 μL of fractionation buffer, and then centrifuged at 10,000 g for 10 min again to isolate the mitochondria. with mitochondrial marker protein HSP60. C. Subcellular fractionation followed by immunoblotting using antibody against SHMT2 suggested that a small amount of SHMT2 is localized in the cytosol. D. The Δ21 mutant of SHMT2 is predominantly localized in the cytosol while the full length SHMT2 has cytosolic and strong puncta (mitochondrial) localization. Table S1 . Potential HDAC11 substrates from SILAC1 (HAP1 cells) Table S2 . Potential HDAC11 substrates from SILAC2 (HCT116 cells) Table S3 . Potential HDAC11 substrates from SILAC3 (MCF-7 cells)
